#ilovelondon: using Twitter to rebuild London’s reputation

The latest issue of Time Out London (n. 2138. 18-24 August 20110) features a white front cover, on which the hashtag “#ilovelondon” stands out boldly in bright red.  This clever initiative aims to encourage people to use the hashtag and tweet about what they like best about the city, in an effort to build London’s reputation again after the riots.  Amidst the furore over the role played by social media Continue reading

UK Riots: What now for retailers?

UK retailers, already struggling to make ends meet during the consumer downturn, now face an added financial burden as they recover from the aftermath of recent riots. Analysts estimate that the violence has cost British retailers over £80 million. Fashion and technology stores like H&M, Debenham’s, Curry’s and Dixons were particular targets of looters. Sony’s distribution centre in Enfield, North London, was was set ablaze. We’ve been watching the situation Continue reading

Measuring Outcomes in Facebook Marketing: IAB Event Recap

It was an honour and a thrill to sponsor last night’s IABUK’s Social Media Event – How to keep the party going – held at the LBi offices on Brick Lane. The event had a great turnout and featured some incredible talks by folks from Torchbox, LinkedIn, Bing and Skive to name a few. Our own Mark Rogers was also speaking on Measuring Outcomes in Facebook Marketing, where our Squishable Continue reading

Fresh Bread Lunch

We have a lovely German colleague working with us at the moment who was telling us how many companies in Germany traditionally have lunch together, a ritual that not only increases solidarity amongst the team but also encourages everyone to take a break from their computers and enjoy a bit of the good life. Inspired, we’ve started a new tradition here at the Market Sentinel Offices: Friday Fresh Bread Lunch. Continue reading

New Facebook Rules: A Challenge and an Opportunity for Pharma

Our latest white paper explores how pharmaceutical companies can manage and benefit from Facebook in light of Facebook’s new policy to require open comments. Yesterday, Pharmalot reported that some drugmakers may abandon Facebook if they can’t cope with the changes. They interviewed several drugmakers about their plans, including Sanofi and AstraZeneca, who acknowledge that they may walk away from Facebook if they cannot overcome concerns posed by the new policy. Continue reading